BUSINESS
Toxic air fuels sale of respiratory drugs, segment grows 14.7% in October
Cipla, a market leader in respiratory segment, advances to the second position from third, replacing Abbott in October
BUSINESS
BlackRock to exit Bengaluru-based People Tree Hospitals
Co-founder and CEO, Dr. Jothi Neeraja, has begun facilitating the exit of US asset manager BlackRock, which invested Rs.210 crore ($24 million) in March 2025
BUSINESS
Rs 10,000 crore lost to health insurance fraud: vague symptoms, mid-ticket bills, and ID swaps top the list
Fraud hotspots are concentrated in retail health policies, reimbursement claims, and mid-ticket bills, the report said.
BUSINESS
Biological E secures WHO prequalification for pneumococcal conjugate vaccine
The WHO prequalification allows the PNEUBEVAX 14 (BE-PCV-14) vaccine to be procured by United Nations agencies and global immunization initiatives.
BUSINESS
From burn to earn: PharmEasy targets profitability by March FY27 under new CEO
Since taking charge as MD & CEO of API Holdings parent of PharmEasy in August, Rahul Guha is pivoting the group from growth-at-any-cost to profit-first execution, tightening costs, rejigging capital, and pushing higher‑margin products and services across the ecosystem.
BUSINESS
Healthium Medtech to invest Rs 150 crore in Andhra Pradesh manufacturing expansion
The new plant will boost production of surgical and post-surgical devices and create 300 direct jobs by 2027, alongside 100 indirect roles in supply chain and ancillary services.
BUSINESS
Telangana police arrest two in $250 million cyber-extortion case linked to Hetero Drugs
The accused, identified as Gadi Manikanta and Yendapalli Jessy Sudarshan, allegedly impersonated USFDA officials using fake email IDs and encrypted messaging apps, including Signal, to pressure Hetero, a release issued by Cyberabad police said.
HEALTH-AND-FITNESS
New generation drugs for cholesterol, fatty liver & kidney disease, and what they promise
These drugs promise faster results with fewer side effects, and in some cases, reversal or slows the disease progression.
BUSINESS
Mankind Pharma hit by domestic slowdown, slow BSV synergy and GST 2.0, but margin guidance intact
Mankind Pharma CEO Sheetal Arora has attributed the slowdown to GST 2.0 disruptions and uneven monsoon.
BUSINESS
AstraZeneca partners with Sun Pharma to expand access to hyperkalaemia treatment Lokelma
Under the agreement, AstraZeneca will sell SZC under the brand Lokelma, while Sun Pharma will distribute it as Gimliand.
BUSINESS
Biocon CEO sees USFDA draft rules potentially slashing biosimilar development costs by half
Global biosimilar development typically costs between $100 million and $200 million, but the U.S. Food and Drug Administration’s updated recommendations aim to eliminate expensive comparative efficacy studies, relying instead on advanced analytical and pharmacokinetic data.
BUSINESS
OneSource Specialty posts Rs 44.9 crore net profit
Chief Executive Officer Neeraj Sharma said the performance was driven by master service agreements and sales from the company’s IP-led base business.
BUSINESS
Eris Lifesciences net profit jumps 39 percent YoY to Rs 134 crore
Revenue rose 6.9 percent YoY to Rs.792 crore.
BUSINESS
Biocon reports Rs 85 crore net profit in Q2FY26
Consolidated revenue grew 11% year-on-year to Rs. 4,389 crore, led by a 25% jump in biosimilars, which contributed 61% of segmental revenue.
BUSINESS
Weight loss drug Wegovy to become cheaper as Novo Nordisk cuts prices by up to 37%
The company announced that the starting dose of Wegovy (0.25 mg) will now cost Rs 2,712 per week, down from Rs.4,336
BUSINESS
Apollo Hospitals says on track for Rs 25,000-crore revenue ahead of FY27 IPO for omnichannel pharmacy & distribution arm
Backed by private equity firm Advent International, Apollo HealthCo—which combines offline pharmacy distribution, digital health services via Apollo 24/7, and the soon-to-be-merged Keimed—has seen a sharp turnaround in profitability.
BUSINESS
Cough and cold medicine sales dip in October as syrup safety concerns mount
This marks the first time in three years that October volumes failed to surpass September, despite the onset of seasonal respiratory illnesses.
BUSINESS
Novo Nordisk partners with Emcure to distribute weight loss drug semaglutide in India
The partnership comes just five months after Wegovy debuted in India, and signals Novo Nordisk’s intent to scale access beyond metro cities and premium clinics.
BUSINESS
DCGI signals end of grace period for small drugmakers, orders immediate inspections under revised Schedule M
The directive from the DCGI, signals an end to the current extension of timeline until December 31, 2025 for thousands of small and medium-sized pharmaceutical firms to comply with the Revised Schedule M rules, warning that "strict action" will be initiated against units that fail to meet the new quality mandates.
BUSINESS
Cipla's Next Chapter: Achin Gupta to succeed Umang Vohra as global CEO, faces innovation challenge
Gupta, currently the Global Chief Operating Officer, will serve as MD & Global CEO-designate starting January 1, 2026. Company executives describe him as Mr Cool and no stranger to innovation and licensing deals.
BUSINESS
Lilly’s Mounjaro is India’s top-selling drug in October
The sales rose to nearly Rs 100 crore, a month-on-month growth of around 25%
BUSINESS
Apollo Hospitals net profit zooms 26% to Rs 477 crore in Q2FY26
Revenue rose 13% YoY to Rs 6,304 crore, while EBITDA grew 15% to Rs 941 crore, with overall margins holding steady at 14.9%.
BUSINESS
GSK India posts Rs 255 crore net profit in Q2FY26
Revenue from operations stood at ₹974 crore, reflecting a temporary topline dip due to GST-related transitions, seasonal disruptions, and a fire at a contract manufacturing site that impacted supply of select general medicines brands.
BUSINESS
Sun Pharma backs speciality play, lines up launches in US amid uncertainty over tariffs
Despite macro uncertainties, Sun Pharma has been bullish on its specialty pipeline and global expansion.
